Atlas Trials

Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous as Induction Therapy in Patients With Active CD or UC

Clinical trial NCT06274294 · UNKNOWN

Trial details

NCT number
NCT06274294
Sponsor
CMC Ambroise Paré
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Inflammatory Bowel Diseases
Start date
2024-07-10
Primary completion
2025-01-01
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.